Healthcare Realty Trust Incorporated (HR)
NYSE: HR · Real-Time Price · USD
20.61
+0.32 (1.58%)
Jul 2, 2026, 4:00 PM EDT - Market closed
Healthcare Realty Trust Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -204.08 | -249.49 | -663.9 | -282.08 | 40.69 | 66.66 |
Depreciation & Amortization | 541.98 | 563.97 | 675.15 | 730.71 | 453.08 | 202.71 |
Stock-Based Compensation | 24.78 | 22.39 | 31.82 | 14.29 | 20.35 | 10.73 |
Other Adjustments | 152.45 | 178.03 | 484.41 | 107.8 | -208.56 | -38.95 |
Changes in Accounts Payable | -16.2 | -25.51 | 5.2 | -18.78 | 24.19 | -0.84 |
Changes in Other Operating Activities | -41.5 | -32.29 | -31.06 | -52.12 | -57 | -7.69 |
Operating Cash Flow | 462.18 | 457.1 | 501.62 | 499.82 | 272.75 | 232.63 |
Operating Cash Flow Growth | -2.34% | -8.88% | 0.36% | 83.25% | 17.24% | -50.51% |
Capital Expenditures | -331.39 | -342.88 | -319.32 | -321.26 | -603.94 | -470.66 |
Sale of Property, Plant & Equipment | 1,022 | 1,007 | 1,221 | 701.43 | 1,201 | 184.22 |
Purchases of Investments | -27.07 | -11.19 | -6.02 | -32.43 | -124.29 | -276.03 |
Proceeds from Sale of Investments | 44.3 | 58.27 | 5.16 | - | 1.69 | - |
Other Investing Activities | - | - | 0.01 | 1.39 | 1,160 | - |
Investing Cash Flow | 704.35 | 710.83 | 900.92 | 349.14 | 1,634 | -562.47 |
Short-Term Debt Issued | 398.22 | 1,449 | 1,289 | 694 | 40 | 210 |
Short-Term Debt Repaid | - | 1,329 | 1,289 | 1,079 | - | - |
Net Short-Term Debt Issued (Repaid) | 398.22 | 2,778 | 2,578 | 1,773 | 40 | 210 |
Long-Term Debt Issued | - | - | - | - | 666.5 | - |
Long-Term Debt Repaid | 886.67 | 916.52 | 375.47 | 19.14 | 1,164 | 24.56 |
Net Long-Term Debt Issued (Repaid) | 886.67 | 916.52 | 375.47 | 19.14 | 1,830 | 24.56 |
Issuance of Common Stock | - | - | 0.1 | 0.13 | 22.9 | 331.12 |
Repurchase of Common Stock | 105.83 | 4.01 | 519.3 | 2.3 | 3.19 | 3.8 |
Net Common Stock Issued (Repurchased) | 105.83 | 4.01 | 519.41 | 2.43 | 26.09 | 334.92 |
Common Dividends Paid | -362.01 | -386.92 | -457.85 | -472.24 | -283.71 | -175.46 |
Other Financing Activities | -5.89 | -23.23 | -6.8 | -5.67 | -1,138 | -9.59 |
Financing Cash Flow | -1,166 | -1,211 | -1,359 | -884.22 | -1,859 | 327.72 |
Net Cash Flow | 0.51 | -42.74 | 43.22 | -35.26 | 47.79 | -2.13 |
Free Cash Flow | 130.8 | 114.22 | 182.3 | 178.57 | -331.19 | -238.03 |
Free Cash Flow Growth | 14.51% | -37.34% | 2.09% | - | - | - |
FCF Margin | 11.41% | 9.79% | 14.56% | 13.46% | -35.95% | -44.86% |
Free Cash Flow Per Share | 0.37 | 0.33 | 0.50 | 0.47 | -1.30 | -1.67 |
Levered Free Cash Flow | 1,237 | 3,612 | 2,629 | 1,852 | 1,727 | 24.74 |
Unlevered Free Cash Flow | 241.23 | 241.92 | 347.06 | 375.57 | -218.97 | -198.92 |